By Dengyuemed International Business Department For decades, global oncology treatments have relied primarily on traditional modalities such as small-molecule inhibitors, antibody therapies, and cell therapies. However, challenges such as drug resistance, undruggable targets, and ...Learn More

Fresh yeast is broken down to release specialty yeast. This is subsequently employed in various food applications. The protein breakdown process in fresh yeast is key to this transformation. The enzymes break down the proteins and dismantle the yeast shell. It results in products ...Learn More

By: DengYue International Business DivisionTen years ago, China was known primarily as a supplier of APIs and low-cost generic medicines to the world. Today, if someone tells you that China is developing, manufacturing, and exporting world-class oncology drugs, biologics, ...Learn More

We all have those moments where we need a five-minute break from work or study, only to look up at the clock and realize an hour has vanished. Browser games are the usual culprits for this time travel, and few do it better than the high-speed, neon-soaked runner known as Slope.If ...Learn More

By DengYueMed International Business DivisionToday, DengYueMed shares key commercial insights into China’s EGFR small-molecule targeted therapy market with international buyers and distribution partners. Drawing on the latest publicly available data, we analyzed the sales trends ...Learn More